Odyssey Health, Inc.: 10-K filed 2020-11-16
What Odyssey Health, Inc. reported in its annual report filed 2020-11-16 (fiscal FY 2021): 30 published measures, 62 facts as tagged in accession 0001683168-20-003913.
This filing
- Form
- 10-K (annual report)
- Filed
- 2020-11-16
- Fiscal period
- fiscal FY 2021
- Accession
- 0001683168-20-003913 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Odyssey Health, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 105,584 | USD | |
| At 2019-07-31 | 536,445 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 757,062 | USD | |
| At 2019-07-31 | 1,130,203 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | -651,478 | USD | |
| At 2019-07-31 | -593,758 | USD | |
| At 2018-07-31 | -819,377 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 62,952 | USD | |
| At 2019-07-31 | 167,095 | USD | |
| At 2018-07-31 | 390 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | -4,348,855 | USD | 366 |
| 2018-08-01 to 2019-07-31 | -23,428,995 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | -649,143 | USD | 366 |
| 2018-08-01 to 2019-07-31 | -104,837 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 0 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 0 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 545,000 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 271,542 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | -28,850,728 | USD | |
| At 2019-07-31 | -24,501,872 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 87,123,187 | shares | 366 |
| 2018-08-01 to 2019-07-31 | 69,898,436 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | -0.05 | USD/shares | 366 |
| 2018-08-01 to 2019-07-31 | -0.34 | USD/shares | 365 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 0 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 0 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 965 | USD | |
| At 2019-07-31 | 1,517 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 2,783,627 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 101,417 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | -3,846,663 | USD | 366 |
| 2018-08-01 to 2019-07-31 | -23,578,713 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 99,619 | USD | |
| At 2019-07-31 | 519,928 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 502,192 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 70,282 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 707,062 | USD | |
| At 2019-07-31 | 1,130,203 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 269,387 | USD | |
| At 2019-07-31 | 47,743 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 0 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 0 | USD | 365 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 0 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 0 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 20,237 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 23,011,400 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 88,559,978 | shares | |
| At 2019-07-31 | 86,990,400 | shares |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 50,000 | USD | |
| At 2019-07-31 | 0 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 5,000 | USD | |
| At 2019-07-31 | 15,000 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-07-31 | 0 | USD | |
| At 2019-07-31 | 0 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 3,846,663 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 23,358,713 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 522 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 551 | USD | 365 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | -161,200 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 44,900 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-07-31 | 221,644 | USD | 366 |
| 2018-08-01 to 2019-07-31 | 21,053 | USD | 365 |
Inspect the source
- Entity
- Odyssey Health, Inc. / CIK 0001626644
- Captured
- 2026-09-19T11:19:48.570Z
- SEC response SHA-256
1be33e1ca79fd1e1d5399b519a2ef141b4c1191380216b92c135e07a22902f7b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001626644.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))